Functional SNPs in human C20orf54 gene influence susceptibility to esophageal squamous cell carcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 12, 2011, Pages 3207-3212

  Ji, Aifang ^a   Wang, Jinsheng ^a   Yang, Jianzhou ^a   Wei, Zibai ^c   Lian, Changhong ^d   Ma, Liang ^a   Ma, Li ^a   Chen, Jinjing ^a   Qin, Xiaoqi ^a   Wang, Lidong ^b   Wei, Wu ^a  

^a Central Laboratory   (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c Department of Endoscopy ^*  (China)

^d Heping Hospital Affiliated to Changzhi Medical University   (China)

Author keywords

C20orf54; China; Esophageal squamous cell carcinoma; Single nucleotide polymorphisms

Indexed keywords

CARRIER PROTEIN; DNA; SLC52A3 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; ESOPHAGUS TUMOR; FEMALE; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROGNOSIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK FACTORS;

EID: 84864511598     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Akbari MR, Malekzadeh R, Nasrollahzadeh D, et al (2006). Familial risks of esophageal cancer among the Turkmen population of the Caspian littoral of Iran. Int J Cancer, 119, 1047-51.
2. Carter CL, Hu N, Wu M, Lin PZ, et al (1992). Segregation analysis of esophageal cancer in 221 high-risk Chinese families. J Natl Cancer Inst, 84, 771-6.
3. Chang-Claude J, Becher H, Blettner M, et al (1997). Familial aggregation of oesophageal cancer in a high incidence area in China. Int J Epidemiol, 26, 1159-65.
4. Daniel H, Wille U, Rehner G (1983). In vitro kinetics of the intestinal transport of riboflavin in rats. J Nutr, 113, 636-43.
5. Dhillon PK, Farrow DC, Vaughan TL, et al (2001). Family history of cancer and risk of esophageal and gastric cancers in the United States. Int J Cancer, 93, 148-52.
6. Garavello W, Negri E, Talamini R, et al (2005). Family history of cancer, its combination with smoking and drinking, and risk of squamous cell carcinoma of the esophagus. Cancer Epidemiol Biomarkers Prev, 14, 1390-3.
7. Ghadirian P (1985). Familial history of esophageal cancer. Cancer, 56, 2112-6.
8. He Y, Ye L, Shan B et al (2009). Effect of riboflavin-fortified salt nutrition intervention on esophageal squamous cell carcinoma in a high incidence area, China. Asian Pac J Cancer Prev, 10, 619-22.
9. Ishiguro S, Sasazuki S, Inoue M, et al (2009). Effect of alcohol consumption, cigarette smoking and f lushing response on esophageal cancer risk: a population-based cohort study (JPHC study). Cancer Lett, 275, 240-6.
10. Islami F, Kamangar F (2008). Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Phila Pa), 1, 329-38.
11. Ji AF, Wei W, Wang JS, et al (2011). Comparison and significance of serum riboflavin levels in patients with esophageal squamous cell carcinoma and the Linzhou migrated subjects from Changzhi, Shanxi. Chin J Intem Med, 50, 1424-6.
12. Ke L (2002). Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970-90. Int J Cancer, 102, 271-4.
13. Kimura MT, Mori T, Conroy J, et al (2005). Two functional coding single nucleotide polymorphisms in STK15 (Aurora-A) coordinately increase esophageal cancer risk. Cancer Res, 65, 3548-54.
14. Larsson SC, Giovannucci E, Wolk A (2006). Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology, 131, 1271-83.
15. Lee CH, Wu DC, Lee JM, et al (2007). Carcinoge-netic impact of alcohol intake on squamous cell carcinoma risk of the oesophagus in relation to tobacco smoking. Eur J Cancer, 43, 1188-99.
16. McCormick DB (1972). The fate of riboflavin in the mammal. Nutr Rev, 30, 75-9.
17. McCormick, DB (1989). Two interconnected B vitamins: riboflavin and pyridoxine. Physiol Rev, 69, 1170-98.
18. Middleton HM 3rd (1990). Uptake of riboflavin by rat intestinal mucosa in vitro. J Nutr, 120, 588-93.
19. Morita M, Saeki H, Mori M, et al (2002). Risk factors for esophageal cancer and the multiple occurrence of carci-noma in the upper aerodigestive tract. Surgery, 131, S1-6.
20. Murtaza I, Mushtaq D, Margoob MA, et al (2006). A study on p53 gene alterations in esophageal squamous cell carcinoma and their correlation to common dietary risk factors among population of the Kashmir valley. World J Gastroenterol, 12, 4033-7.
21. Pandeya N, Williams G, Green AC, et al (2009). Alcohol consumption and the risks of adeno-carcinoma and squamous cell carcinoma of the esophagus. Gastroenterology, 136, 1215-24.
22. Pandeya N, Williams GM, Sadhegi S, et al (2008). Associations of duration, intensity, and quantity of smoking with adenocarcinoma and squamous cell carcinoma of the esopha-gus. Am J Epidemiol, 168, 105-14.
23. Powers HJ (2003). Riboflavin (vitamin B-2) and health. Am J Clin Nutr, 77, 1352-60.
24. Said HM (2004). Recent advances in carrier-mediated intestinal absorption of water-soluble vitamins. Annu Rev Physiol, 66, 419-46.
25. Said HM, Arianas P (1991). Transport of riboflavin in human intestinal brush border membrane vesicles. Gastroenterology, 100, 82-8.
26. Said HM, Ma TY (1994). Mechanism of riboflavine uptake by Caco-2 human intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol, 266, G15-21.
27. Said HM, Ortiz A, Moyer MP, et al (2000). Riboflavin uptake by human-derived colonic epithe-lial NCM460 cells. Am J Physiol Cell Physiol, 278, C270-6.
28. Shao YN, Shen J, Tan YF (1997). A study on the etiology and epidemiology of familial aggregation in arteriosclerotic cerebral infarction. Zhong hua Liu Xing Bing Xue Za Zhi, 18, 275-8.
29. Siassi F, Ghadirian P (2005). Riboflavin deficiency and esophageal cancer: a case control-household study in the Caspian Littoral of Iran. Cancer Detect Prev, 29, 464-9.
30. Tavani A, Negri E, Franceschi S, et al (1994). Risk factors for esophageal cancer in lifelong nonsmokers. Cancer Epidemiol Biomarkers Prev, 3, 387-92.
31. Taylor PR, Wang G-Q, Dawsey SM, et al (1995). Effect of nutrition intervention on intermediate endpoints in esophageal and gastric carcinogenesis. Am J Clin Nutr, 62, S1420-3.
32. Tomei, S, Yuasa, H, Inoue, K, et al (2001). Transport functions of riboflavin carriers in the rat small intestine and colon: site difference and effects of tricyclic-type drugs. Drug Deliv, 8, 119-24.
33. Van Rensburg SJ (1981). Epidemiological and dietary evidence for a specific nutritional predisposition to esophageal cancer. J Natl Cancer Inst, 67, 243-51.
34. Yang SJ, Wang HY, Li XQ, et al (2007). Genetic polymorphisms of ADH2 and ALDH2 association with esophageal cancer risk in southwest China. World J Gastroenterol, 13, 5760-4.
35. Zhang W, Bailey-Wilson JE, Li W, et al (2000). Segregation analysis of esophageal cancer in a moderately high-incidence area of northern China. Am J Hum Genet, 67,110-9.
36. Zhang X, Miao X, Tan W, et al (2005). Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology, 129, 565-76.